Vanguard Capital Management
ADIL

Vanguard Capital Management’s Adial Pharmaceuticals ADIL Stock Holding History

Vanguard Capital Management’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9K Buy
5,831
+5,470
+1,515% +$10.8K ﹤0.01% 4028
2026
Q1 		$646 Buy
+361
New +$1.27K ﹤0.01% 4055

Other funds holding ADIL

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Manchester Capital Management Manchester, Vermont $768M AUM 29.32% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's ADIL Position: Q2 2026 in Review

Vanguard Capital Management increased its Adial Pharmaceuticals (ADIL) stake by 1,515% in Q2 2026, buying an estimated $10.8K and bringing the position to 5,831 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4028.

Vanguard Capital Management first reported a position in ADIL in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.

  • Vanguard Capital Management held 5,831 shares of Adial Pharmaceuticals worth $14.9K as of Q2 2026.
  • Vanguard Capital Management bought 5,470 Adial Pharmaceuticals shares in Q2 2026, an estimated $10.8K.
  • Adial Pharmaceuticals made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #4028 holding.
  • Vanguard Capital Management first reported a position in Adial Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.